Sign in Subscribe

clinical trial

Is Foundayo safe long term? What the clinical trial data actually shows

Is Foundayo safe long term? What the clinical trial data actually shows

Is Foundayo safe long term? What the clinical trial data actually shows Foundayo (orforglipron) represents the first oral GLP-1 receptor agonist approved for type 2 diabetes, offering patients an alternative to daily injections. However, understanding its long-term safety requires careful examination of available clinical trial data and ongoing

GLP-1 side effects: What 400,000 patient reports reveal

GLP-1 side effects: What 400,000 patient reports reveal

GLP-1 side effects: What 400,000 patient reports reveal GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have become some of the most prescribed medications in the country. Millions of people take them for Type 2 diabetes and weight management, and for good reason — the

UCLA: Doing this before surgery cuts complications by nearly half

UCLA: Doing this before surgery cuts complications by nearly half

By Stephen Beech Prehab is the best way to ensure patients fully recover from major surgery, according to a new study. Optimizing exercise and nutrition before going under the knife — known as prehabilitation or "prehab" — boosts patient recovery, say doctors. Programs that support patients' health before surgery

Advocacy groups respond to new executive order on psychedelics

(The Center Square) – Some say President Donald Trump’s new executive order on psychedelics goes too far, while others say it’s a good first step, but more action is needed. The president signed an executive order over the weekend aimed at making psychedelic treatments for mental illness accessible to

Stem cell therapy for cerebral palsy moves closer to US trials

Stem cell therapy for cerebral palsy moves closer to US trials

Stem cell therapy for cerebral palsy moves closer to US trials Cerebral palsy affects roughly 1 in 345 children in the United States. About 764,000 children and adults live with the condition. Standard treatment focuses on managing symptoms through physical therapy, medications, and assistive devices. None of these treatments

FDA crackdown targets unpublished research results

(The Center Square) – The U.S. Food and Drug Administration issued more than 2,200 notices urging companies and researchers to comply with federal publication rules. A recent FDA crackdown highlights transparency issues in clinical research, as thousands of companies and researchers have failed to disclose required trial results. Some

How long young cancer patients survive often depends on the insurance they have

How long young cancer patients survive often depends on the insurance they have

Cancer is becoming increasingly common among young people, with cases slowly and steadily rising every year for the past decade. And what type of insurance adolescents and young adults have affects at what stage of cancer they’re diagnosed and how long they survive. As researchers who study cancer disparities